Delivery Order SPE2DE23D0008-SPE2D625F3XK2
- Not listed
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,990 fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain division on July 10, 2025, for Natrelle TE Smooth 133S breast implants. This delivery order, which carries an ultimate completion date of July 28, 2025, represents a child award under one of Allergan's two significant Indefinite Delivery Vehicle contracts established with DLA Troop Support Medical on December 8, 2022. The award was made without...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,814 fixed-price delivery order for Natrelle Inspira SCM 330cc breast implants by the Defense Logistics Agency (DLA) Troop Support Medical on September 5, 2025. This delivery order, which has no set-aside designation, is a child contract stemming from one of Allergan's larger Indefinite Delivery Vehicles—specifically the $13.5 million Natrelle breast implants and surgical devices IDV established on December 8, 2022. The order is...
- Allergan USA Inc., a subsidiary of Abbvie Inc., has been awarded a $1,495 fixed-price delivery order by the Defense Logistics Agency Troop Support Medical to provide 4563183739 NATRELLE TE Smooth 133S-MX-12-T breast implants. The order was awarded on December 14, 2023 under the company's $13.5 million Indefinite Delivery Indefinite Quantity contract, which supplies breast implants, surgical instruments, and specialty components to support reconstructive surgeries at Military Treatment...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,614.00 fixed-price delivery order on September 19, 2025, for Natrelle Inspira SCM 445CC breast implants through the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The contract carries an ultimate completion date of September 23, 2025, and will be performed in Irvine, California. This delivery order was issued without set-aside designation, reflecting Allergan's sole-source supplier status for specialized...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $5,421.00 fixed-price delivery order contract by the Defense Logistics Agency Medical Supply Chain on July 21, 2025, for Natrelle Inspira SSM 210CC breast implants. The contract, which carries an ultimate completion date of July 23, 2025, will be performed at Allergan's facility in Irvine, California. This delivery order was awarded without set-aside designation, reflecting Allergan's status as the sole-source provider of these...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,092.00 fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain division for Inspira SRLP 205CC breast implants. The award, made on September 11, 2025, with an ultimate completion date of September 22, 2025, represents a child delivery order under one of Allergan's larger Indefinite Delivery Vehicle contracts for Natrelle breast implants and surgical devices valued at $13.5 million. The contract utilizes...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order on September 11, 2025, by the Defense Logistics Agency's Medical Supply Chain division for 4569553905 Inspira SRF 385CC breast implants, valued at $1,110.00. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of September 25, 2025, and represents performance work to be completed at Allergan's facility in Irvine, California. The award utilizes no set-aside designation,...
- Allergan USA Inc., a subsidiary of Abbvie Inc., has been awarded a $1,495 delivery order by the Defense Logistics Agency Troop Support Medical to supply Natrelle TE Smooth 133S-MV-12-T breast implants for reconstructive procedures. The fixed-price contract has an economic price adjustment clause and performance will occur at Allergan's facility in Irvine, California. No set-aside designation was applied. This award is associated with Allergan's role as the sole-source provider of the proprietary...
- The Defense Logistics Agency Medical Supply Chain awarded a $1,495.00 fixed-price delivery order to Allergan USA Inc. on September 15, 2025, for Natrelle TE Smooth 133S-MV-14-T breast implants. This delivery order, which represents a child contract under one of Allergan's larger Indefinite Delivery Vehicles, is scheduled for completion by September 17, 2025, with the place of performance in Irvine, California. The contract includes economic price adjustment provisions and was awarded without...
- Allergan USA Inc., a subsidiary of AbbVie Inc., received a $2,814 fixed-price delivery order from the Defense Logistics Agency (DLA) Medical Supply Chain on September 16, 2025, for Natrelle Inspira SCF 605CC breast implants. This delivery order, with an ultimate completion date of September 18, 2025, represents a child contract issued without set-aside designation, reflecting Allergan's status as a sole-source provider of specialized surgical devices to federal healthcare systems. The place of...
- SPE2DE23D0008Indefinite Delivery Contract
- SPE2DE23D0008-SPE2D625F3XK2Delivery Order
Allergan USA Inc., a subsidiary of AbbVie Inc., received a $9,109 fixed-price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical on June 26, 2025, for Natrelle TE Smooth 133S-MV-11-T breast implants. This delivery order, which carries no set-aside designation, is scheduled for completion by June 30, 2025, with performance to be executed in Irvine, California. The award represents a child contract action under one of Allergan's two significant Indefinite Delivery Vehicles established with DLA Troop Support Medical in December 2022—specifically the $13.5 million IDV for Natrelle breast implants and surgical devices. The contract utilizes fixed-price pricing with economic price adjustment, consistent with DLA's standard contracting approach for medical device procurement. Allergan's Natrelle-branded implants support reconstructive and aesthetic surgical procedures across Department of Defense treatment facilities, Veterans Affairs hospitals, and Indian Health Service centers, serving military members, veterans, and Native American populations. As a sole-source provider of these specialized medical devices, Allergan maintains a critical role in the federal medical supply chain, with its recent contract awards demonstrating consistent demand for its implant products across the military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.1k | 6/26/25 |